10.02.2020 | Tracker

Survival milestone contributes to fresh hope for pancreatic cancer in 2020

By Jamie Doggett

Survival milestone contributes to fresh hope for pancreatic cancer in 2020

Receive monthly updates on the ongoing pancreatic cancer conversation from HCPs online. Sign up for these insights to be delivered direct to your inbox.

As we entered 2020, healthcare professionals continued to engage in conversation relating to a high profile diagnosis of U.S. Representative John Lewis with stage IV pancreatic cancer.

In early January, HCPs were very enthusiastic in sharing a milestone in pancreatic cancer survival rate. The American Cancer Society and National Cancer Institute published results reporting the five-year survival rate of pancreatic cancer has, for the first time, reached 10%.

There were thanks given to all the organisations and individuals who have been working so hard to bring better survivorship to this challenging disease. The results also gave cause to look to the future. Suneel Kamath, a Gastrointestinal Oncologist at the Cleveland Clinic, echoed the hope the results bring but also looked to the 90% as the remaining work to be done.

A large part of the online HCP conversation this month was around GI20 (the 2020 Gastrointestinal Cancers Symposium). HCPs were actively sharing highlights of the symposium including data and summaries of study results. There were a number of negative clinical trials shared at the conference. Wungki Park, a Manhattan-based medical oncologist, was retweeted by his HCP peers as he shared three of these with photos he was taking of the results on screen.

Despite the negative trials there was still a sense  of undamped optimism for new treatments in pancreatic cancer. GI Medical Oncologist, Mohamed Salem, was praised by his peers for his attitude to ‘keep trying’.

During the event PeerView streamed a question and answer session live in which HCPs answered audience questions regarding optimal treatment strategies in pancreatic cancer. The link was tweeted by PeerView and shared by 21 HCPs as they sought to give access to the session to a wider audience.

New data and statistics demonstrating incremental success in treating pancreatic cancer have brought fresh hope to those fighting the disease in 2020. Follow our HCP conversations in pancreatic cancer tracker and keep up to date with other pharmaceutical tracking updates within the Tracking section of CREATION Knowledge, or by signing up to our monthly eJournal.


High profile diagnosis draws HCP sympathy


  • This article analysed the Twitter conversations of HCPs in the US, between January 1st – February 5th 2020, using CREATION Pinpoint®.
  • Between January 1st – February 5th 2020, 1,303 US HCPs posted over 2,500 posts about pancreatic cancer on Twitter.

The cover image is a false colour SEM image of pancreatic cancer cells, grown in culture.
CREDIT: Anne Weston, Francis Crick Institute used under Creative Commons License.

View all articles >

Meet the Author

Jamie Doggett

As Associate Director of Insight, Jamie leads the Analytics and Insights Team overseeing the development of insights. He works with teams to ensure the highest standards of research outputs, client delivery, and technology development.

Jamie is a country boy at heart having grown up on the sunny Isle of Wight and enjoys adventures which is reflected in a love for travel and travel literature.

Suggested next

13.12.2023 | Article

Product Launch Tracker: eHCPs optimistic about Wegovy competitor’s obesity approval

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

13.09.2018 | Whitepaper

White Paper: Collective intelligence on emerging CAR-T cell therapies

With hundreds of new CAR-T cell therapies under development

View all articles >